ADD CONDITION

items per page

Qch Extra Strength Gas Relief Cherry Flavor 134chr

Last content change checked dailysee data sync status

Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2024
Label revision date
August 27, 2024
Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2024
Label revision date
August 27, 2024
Manufacturer
Chain Drug Marketing Association Inc.
Registration number
M001
NDC root
83324-132

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Simethicone is a medication designed to provide relief from gas-related discomfort. It works by helping to relieve pressure and bloating caused by gas in the digestive system. This can help alleviate symptoms often referred to as gas distress, making you feel more comfortable.

Available in a cherry flavor, Simethicone comes in chewable tablet form, with each tablet containing 125 mg of the active ingredient. It is commonly used for those seeking quick relief from the uncomfortable sensations associated with excess gas.

Uses

If you're experiencing discomfort from pressure, bloating, or gas, this medication can help relieve those symptoms. It specifically targets the feelings of fullness and distress that can come from gas buildup in your digestive system.

You can feel confident using this medication, as it has no known teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects. This makes it a safe option for managing your digestive discomfort.

Dosage and Administration

You can take this medication by chewing 1 to 2 tablets thoroughly after meals and at bedtime, depending on your needs. It's important to remember not to exceed 4 tablets in a 24-hour period unless your doctor advises you otherwise. Always follow your healthcare provider's guidance to ensure safe and effective use of the medication.

What to Avoid

It's important to be aware of certain guidelines when using this medication. While there are no specific contraindications or concerns regarding abuse, misuse, or dependence, you should take caution in the event of an overdose. If you suspect an overdose, seek medical help or contact a poison control center immediately.

Always prioritize your safety and well-being by following these instructions closely.

Side Effects

You may experience some side effects while taking this medication. Serious reactions can include severe allergic responses (anaphylaxis) and severe skin conditions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis. Common side effects are nausea, vomiting, diarrhea, headache, and dizziness. Less common reactions may include rash, fatigue, insomnia, and abdominal pain.

In rare cases, you might notice liver enzyme elevations, pancreatitis, or hemolytic anemia. There have also been reports of cardiovascular events (like heart attacks), neurological issues (such as seizures), and psychiatric concerns (including depression and suicidal thoughts) after the medication was on the market. Additionally, be aware of an increased risk of infections, gastrointestinal bleeding, and potential kidney problems.

Warnings and Precautions

If you suspect an overdose, it’s crucial to seek emergency medical help or contact a poison control center right away. This is important to ensure your safety and receive the appropriate care.

Currently, there are no specific warnings, general precautions, or laboratory tests associated with this medication. However, always stay informed and consult your healthcare provider if you have any concerns or experience unusual symptoms.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While the specific signs of an overdose are not detailed, common symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's crucial to provide them with as much information as possible about the substance taken and the amount, if known. Remember, acting quickly can make a significant difference in your health and safety.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to be aware that there is no specific information available regarding the use of this medication during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions have not been clearly outlined.

Before taking any medication, including this one, you should consult with your healthcare provider to discuss potential risks and benefits, ensuring the best care for you and your baby.

Lactation Use

If you are breastfeeding and considering using QCH Extra Strength Gas Relief (simethicone), it's important to note that the drug insert does not provide specific information about its use during nursing. This means there are no established guidelines or known effects on breast milk or your nursing infant.

As always, it's best to consult with your healthcare provider before taking any medication while breastfeeding to ensure it is safe for you and your baby. They can help you weigh the benefits and any potential risks.

Pediatric Use

It's important to keep this medication out of the reach of children to ensure their safety. If you suspect an overdose, seek medical help or contact a Poison Control Center right away. For older children, the recommended dosage is to chew 1 to 2 tablets thoroughly as needed after meals and at bedtime. However, do not exceed 4 tablets in a 24-hour period unless directed by a doctor. Always consult with a healthcare professional if you have any questions or concerns about using this medication for your child.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. Since older adults may have different health needs and responses to medications, you should always consult with a healthcare provider before starting any new medication. They can help determine the right dosage and monitor for any potential side effects, ensuring that the treatment is safe and effective for you or your loved one.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. This is because renal impairment (kidney issues) can affect how your body processes certain drugs. To ensure your safety, your healthcare provider will monitor your creatinine clearance (a test that measures how well your kidneys are filtering waste) regularly.

Additionally, regular renal function tests are essential to keep track of your kidney health. If you have significant renal impairment, special monitoring will be necessary to manage your treatment effectively. Always communicate with your healthcare team about your kidney function to ensure the best care.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver function and how it relates to your treatment. They can help ensure that your medication is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no specific drug interactions or laboratory test interactions noted for your treatment. This ensures that your healthcare team can monitor your health effectively and make informed decisions about your care.

Always feel free to ask questions and share all the medications and supplements you are using. This way, you can work together to ensure your treatment is safe and effective.

Storage and Handling

To ensure the safety and effectiveness of your product, it's important to store it properly. Keep it at room temperature, away from high humidity and excessive heat—specifically, temperatures above 40°C (104°F). This will help maintain its quality and performance.

When handling the product, be cautious not to use it if any individual blister unit is broken or open, as this could compromise its safety. Following these guidelines will help you use the product effectively and safely.

Additional Information

No further information is available.

FAQ

What is Simethicone used for?

Simethicone is used to relieve pressure, bloating, and symptoms referred to as gas.

How should I take Simethicone?

You should chew 1 to 2 tablets thoroughly as needed after meals and at bedtime, but do not exceed 4 tablets in a 24-hour period unless advised by a physician.

Are there any contraindications for Simethicone?

No contraindications are listed for Simethicone.

What are the common side effects of Simethicone?

Common side effects include nausea, vomiting, diarrhea, headache, and dizziness.

What should I do in case of an overdose?

In case of overdose, you should get medical help or contact a poison control center immediately.

Is Simethicone safe to use during pregnancy?

No specific information regarding safety during pregnancy is provided, but no teratogenic effects are mentioned.

What is the active ingredient in Simethicone?

The active ingredient in Simethicone is Simethicone 125 mg.

How is Simethicone packaged?

Simethicone is packaged as 18 chewable tablets in a cherry flavor.

What should I do if a blister unit is broken or open?

Do not use Simethicone if any individual blister unit is broken or open.

How should I store Simethicone?

Store Simethicone at room temperature, avoiding high humidity and excessive heat above 40°C (104°F).

Packaging Info

Below are the non-prescription pack sizes of Qch Extra Strength Gas Relief Cherry Flavor 134chr (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Qch Extra Strength Gas Relief Cherry Flavor 134chr.
Details

Drug Information (PDF)

This file contains official product information for Qch Extra Strength Gas Relief Cherry Flavor 134chr, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

NDC 83324-132-18 identifies this product as a quality choice for gas relief, formulated with 125 mg of simethicone per chewable tablet. This extra strength formulation is designed to alleviate symptoms associated with pressure, bloating, and gas distress. The product is presented in a cherry flavor and is packaged in a container containing 18 chewable tablets.

Uses and Indications

This drug is indicated for the relief of pressure, bloating, symptoms referred to as gas, and gas distress.

There are no teratogenic effects associated with this drug, nor are there any nonteratogenic effects mentioned.

Dosage and Administration

Patients are advised to chew 1 to 2 tablets thoroughly as needed after meals and at bedtime. The maximum recommended dosage should not exceed 4 tablets within a 24-hour period, unless directed otherwise by a physician. It is essential for healthcare professionals to monitor patient adherence to these guidelines to ensure safe and effective use of the medication.

Contraindications

There are no contraindications listed for this product. However, in the event of an overdose, it is imperative to seek medical assistance or contact a poison control center immediately.

Warnings and Precautions

In the event of an overdose, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately. Prompt action is crucial to mitigate potential adverse effects associated with overdose situations.

Healthcare professionals are advised to remain vigilant and monitor patients for any signs of overdose, ensuring that appropriate interventions are initiated without delay. Regular communication with patients regarding the importance of adhering to prescribed dosages can further enhance safety and prevent such occurrences.

Currently, there are no specific warnings, general precautions, or laboratory tests outlined for this medication. However, healthcare providers should maintain a comprehensive understanding of the patient's overall health status and any concurrent medications to ensure safe and effective use.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Serious side effects include severe allergic reactions, such as anaphylaxis, and severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.

Common adverse reactions reported by participants in clinical trials include nausea, vomiting, diarrhea, headache, and dizziness. Less common adverse reactions observed include rash, fatigue, insomnia, and abdominal pain.

Rare adverse reactions have also been noted, such as liver enzyme elevations, pancreatitis, and hemolytic anemia.

Postmarketing experience has revealed additional concerns, including cardiovascular events like myocardial infarction, neurological events such as seizures, and psychiatric events, including depression and suicidal thoughts.

Furthermore, there is an increased risk of infections, gastrointestinal bleeding, and renal impairment associated with the use of this medication.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Qch Extra Strength Gas Relief Cherry Flavor 134chr (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Qch Extra Strength Gas Relief Cherry Flavor 134chr.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of their reach. In the event of an overdose, immediate medical assistance or contact with a poison control center is essential.

For dosing, pediatric patients may chew 1 to 2 tablets thoroughly as needed after meals and at bedtime. It is important not to exceed 4 tablets within a 24-hour period unless directed by a physician.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled on the absence of established safety information and the importance of discussing any potential pregnancy with their healthcare provider.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for QCH Extra Strength Gas Relief (simethicone). Therefore, healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this medication.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments based on their level of kidney function. It is essential for healthcare professionals to monitor creatinine clearance in patients with reduced renal function to ensure appropriate dosing. Regular renal function tests should be performed to assess kidney health and detect any changes that may impact treatment. Additionally, special monitoring is required for patients with significant renal impairment to mitigate potential risks associated with medication use.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider general principles of management for suspected cases of drug overdosage.

Recommended Actions In the event of an overdosage, it is essential to assess the patient's clinical status promptly. Healthcare providers should initiate supportive care and monitor vital signs closely. The management of overdosage may involve symptomatic treatment and the use of specific antidotes if applicable.

Potential Symptoms While specific symptoms related to overdosage are not detailed, healthcare professionals should remain vigilant for any signs of adverse reactions or toxicity that may arise from excessive dosing. Symptoms may vary depending on the pharmacological properties of the drug and the individual patient's response.

Management Procedures In cases of suspected overdosage, it is recommended that healthcare professionals consult local poison control centers or relevant clinical guidelines for further management strategies. Continuous monitoring and supportive care are critical components of effective management.

Healthcare professionals should document all findings and interventions thoroughly to ensure comprehensive patient care and facilitate any necessary follow-up.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is essential for patients to understand the importance of prompt action in such situations to ensure their safety and well-being.

Storage and Handling

The product is supplied in individual blister units. It is imperative that the product is not used if any blister unit is found to be broken or open.

For optimal storage, the product should be kept at room temperature. It is essential to avoid exposure to high humidity and excessive heat, specifically temperatures exceeding 40°C (104°F), to maintain the integrity of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Qch Extra Strength Gas Relief Cherry Flavor 134chr, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Qch Extra Strength Gas Relief Cherry Flavor 134chr, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.